The pharmaceutical industry is witnessing growing demand for anti-malarial and immunomodulatory therapies, supporting the expansion of the chloroquine market globally. Rising healthcare investments, increasing prevalence of infectious diseases, and the need for affordable treatment solutions are contributing to market growth. Chloroquine market is expected to register a CAGR of 8.09% from 2026...